Ashima Limited (ASHIMASYN.NS) Stock Competitors & Peer Comparison

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, PAGEIND.NS has a market cap of 474.2B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while PAGEIND.NS trades at ₹42,510.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas PAGEIND.NS's P/E ratio is 60.06. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to PAGEIND.NS's ROE of +0.53%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to PAGEIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check PAGEIND.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, PAGEIND.BO has a market cap of 471.8B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while PAGEIND.BO trades at ₹42,455.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas PAGEIND.BO's P/E ratio is 59.97. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to PAGEIND.BO's ROE of +0.53%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to PAGEIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check PAGEIND.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, KPRMILL.NS has a market cap of 402.9B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while KPRMILL.NS trades at ₹1,178.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas KPRMILL.NS's P/E ratio is 47.34. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to KPRMILL.NS's ROE of +0.16%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to KPRMILL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check KPRMILL.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, KPRMILL.BO has a market cap of 402.6B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while KPRMILL.BO trades at ₹1,179.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas KPRMILL.BO's P/E ratio is 46.61. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to KPRMILL.BO's ROE of +0.16%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to KPRMILL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check KPRMILL.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, VTL.NS has a market cap of 191.5B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while VTL.NS trades at ₹661.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas VTL.NS's P/E ratio is 25.26. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to VTL.NS's ROE of +0.07%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to VTL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check VTL.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, VTL.BO has a market cap of 191.5B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while VTL.BO trades at ₹661.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas VTL.BO's P/E ratio is 25.31. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to VTL.BO's ROE of +0.07%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to VTL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check VTL.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, WELSPUNLIV.NS has a market cap of 162.7B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while WELSPUNLIV.NS trades at ₹169.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas WELSPUNLIV.NS's P/E ratio is 37.16. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to WELSPUNLIV.NS's ROE of +0.04%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to WELSPUNLIV.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check WELSPUNLIV.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, WELSPUNLIV.BO has a market cap of 162B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while WELSPUNLIV.BO trades at ₹169.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas WELSPUNLIV.BO's P/E ratio is 74.62. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to WELSPUNLIV.BO's ROE of +0.04%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to WELSPUNLIV.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check WELSPUNLIV.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, ALOKTEXT.BO has a market cap of 161.2B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while ALOKTEXT.BO trades at ₹37.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas ALOKTEXT.BO's P/E ratio is -0.72. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to ALOKTEXT.BO's ROE of N/A. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to ALOKTEXT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check ALOKTEXT.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, WELSPUNIND.NS has a market cap of 153B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while WELSPUNIND.NS trades at ₹159.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas WELSPUNIND.NS's P/E ratio is 29.39. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to WELSPUNIND.NS's ROE of +0.05%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to WELSPUNIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check WELSPUNIND.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, ARVIND.NS has a market cap of 143.3B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while ARVIND.NS trades at ₹546.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas ARVIND.NS's P/E ratio is 30.31. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to ARVIND.NS's ROE of +0.11%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to ARVIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check ARVIND.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, ARVIND.BO has a market cap of 142.9B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while ARVIND.BO trades at ₹546.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas ARVIND.BO's P/E ratio is 33.77. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to ARVIND.BO's ROE of +0.11%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to ARVIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check ARVIND.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, TRIDENT.BO has a market cap of 133.8B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while TRIDENT.BO trades at ₹26.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas TRIDENT.BO's P/E ratio is 35.03. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to TRIDENT.BO's ROE of +0.08%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to TRIDENT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check TRIDENT.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, SWANENERGY.NS has a market cap of 103.8B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while SWANENERGY.NS trades at ₹331.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas SWANENERGY.NS's P/E ratio is 13.68. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to SWANENERGY.NS's ROE of +0.04%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to SWANENERGY.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SWANENERGY.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, MANYAVAR.BO has a market cap of 97.7B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while MANYAVAR.BO trades at ₹402.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas MANYAVAR.BO's P/E ratio is 25.94. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to MANYAVAR.BO's ROE of +0.21%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to MANYAVAR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check MANYAVAR.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, PGIL.NS has a market cap of 91.3B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while PGIL.NS trades at ₹1,975.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas PGIL.NS's P/E ratio is 34.72. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to PGIL.NS's ROE of +0.22%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to PGIL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check PGIL.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, PGIL.BO has a market cap of 91.2B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while PGIL.BO trades at ₹1,973.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas PGIL.BO's P/E ratio is 32.83. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to PGIL.BO's ROE of +0.22%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to PGIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check PGIL.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, ICIL.NS has a market cap of 85.5B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while ICIL.NS trades at ₹431.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas ICIL.NS's P/E ratio is 120.59. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to ICIL.NS's ROE of +0.05%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to ICIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check ICIL.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, ABFRL.NS has a market cap of 75.9B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while ABFRL.NS trades at ₹62.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas ABFRL.NS's P/E ratio is -9.97. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to ABFRL.NS's ROE of -0.12%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to ABFRL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check ABFRL.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, GARFIBRES.BO has a market cap of 72.9B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while GARFIBRES.BO trades at ₹730.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas GARFIBRES.BO's P/E ratio is 36.46. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to GARFIBRES.BO's ROE of +0.15%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to GARFIBRES.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check GARFIBRES.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, GARFIBRES.NS has a market cap of 71.4B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while GARFIBRES.NS trades at ₹730.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas GARFIBRES.NS's P/E ratio is 31.21. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to GARFIBRES.NS's ROE of +0.15%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to GARFIBRES.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check GARFIBRES.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, ALOKINDS.NS has a market cap of 64.2B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while ALOKINDS.NS trades at ₹12.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas ALOKINDS.NS's P/E ratio is -9.89. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to ALOKINDS.NS's ROE of +0.04%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to ALOKINDS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check ALOKINDS.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, GOKEX.NS has a market cap of 62.4B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while GOKEX.NS trades at ₹851.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas GOKEX.NS's P/E ratio is 61.99. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to GOKEX.NS's ROE of +0.05%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to GOKEX.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check GOKEX.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, RAYMONDLSL.BO has a market cap of 47.2B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while RAYMONDLSL.BO trades at ₹775.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas RAYMONDLSL.BO's P/E ratio is 34.52. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to RAYMONDLSL.BO's ROE of +0.00%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to RAYMONDLSL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check RAYMONDLSL.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, RAYMONDLSL.NS has a market cap of 47.2B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while RAYMONDLSL.NS trades at ₹774.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas RAYMONDLSL.NS's P/E ratio is 30.11. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to RAYMONDLSL.NS's ROE of +0.00%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to RAYMONDLSL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check RAYMONDLSL.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, GBGLOBAL.NS has a market cap of 46.5B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while GBGLOBAL.NS trades at ₹930.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas GBGLOBAL.NS's P/E ratio is 74.76. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to GBGLOBAL.NS's ROE of +0.06%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to GBGLOBAL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check GBGLOBAL.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, LUXIND.NS has a market cap of 38.6B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while LUXIND.NS trades at ₹1,282.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas LUXIND.NS's P/E ratio is 37.15. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to LUXIND.NS's ROE of +0.06%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to LUXIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check LUXIND.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, LUXIND.BO has a market cap of 38.5B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while LUXIND.BO trades at ₹1,279.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas LUXIND.BO's P/E ratio is 37.05. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to LUXIND.BO's ROE of +0.06%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to LUXIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check LUXIND.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, MAYURUNIQ.BO has a market cap of 38.3B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while MAYURUNIQ.BO trades at ₹882.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas MAYURUNIQ.BO's P/E ratio is 19.98. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to MAYURUNIQ.BO's ROE of +0.19%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to MAYURUNIQ.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check MAYURUNIQ.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, TCNSBRANDS.BO has a market cap of 37B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while TCNSBRANDS.BO trades at ₹584.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas TCNSBRANDS.BO's P/E ratio is -11.87. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to TCNSBRANDS.BO's ROE of -0.63%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to TCNSBRANDS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check TCNSBRANDS.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, TCNSBRANDS.NS has a market cap of 36.9B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while TCNSBRANDS.NS trades at ₹583.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas TCNSBRANDS.NS's P/E ratio is -11.85. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to TCNSBRANDS.NS's ROE of -0.63%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to TCNSBRANDS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check TCNSBRANDS.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, KITEX.BO has a market cap of 31.7B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while KITEX.BO trades at ₹158.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas KITEX.BO's P/E ratio is 546.21. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to KITEX.BO's ROE of +0.01%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to KITEX.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check KITEX.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, KITEX.NS has a market cap of 31.6B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while KITEX.NS trades at ₹158.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas KITEX.NS's P/E ratio is 546.48. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to KITEX.NS's ROE of +0.01%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to KITEX.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check KITEX.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, KKCL.BO has a market cap of 31.3B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while KKCL.BO trades at ₹507.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas KKCL.BO's P/E ratio is 22.19. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to KKCL.BO's ROE of +0.16%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to KKCL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check KKCL.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, KKCL.NS has a market cap of 31.2B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while KKCL.NS trades at ₹506.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas KKCL.NS's P/E ratio is 24.93. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to KKCL.NS's ROE of +0.16%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to KKCL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check KKCL.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, JINDWORLD.NS has a market cap of 29.9B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while JINDWORLD.NS trades at ₹29.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas JINDWORLD.NS's P/E ratio is 40.34. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to JINDWORLD.NS's ROE of +0.08%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to JINDWORLD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check JINDWORLD.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, JINDWORLD.BO has a market cap of 29.8B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while JINDWORLD.BO trades at ₹29.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas JINDWORLD.BO's P/E ratio is 43.07. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to JINDWORLD.BO's ROE of +0.08%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to JINDWORLD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check JINDWORLD.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, GANECOS.NS has a market cap of 28.8B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while GANECOS.NS trades at ₹1,075.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas GANECOS.NS's P/E ratio is 73.32. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to GANECOS.NS's ROE of +0.03%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to GANECOS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check GANECOS.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, GANECOS.BO has a market cap of 28.8B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while GANECOS.BO trades at ₹1,074.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas GANECOS.BO's P/E ratio is 73.23. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to GANECOS.BO's ROE of +0.03%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to GANECOS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check GANECOS.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, SIYSIL.BO has a market cap of 28.7B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while SIYSIL.BO trades at ₹629.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas SIYSIL.BO's P/E ratio is 12.37. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to SIYSIL.BO's ROE of +0.17%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to SIYSIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SIYSIL.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, SIYSIL.NS has a market cap of 28.5B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while SIYSIL.NS trades at ₹629.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas SIYSIL.NS's P/E ratio is 12.36. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to SIYSIL.NS's ROE of +0.17%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to SIYSIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SIYSIL.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, SPAL.NS has a market cap of 27.8B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while SPAL.NS trades at ₹1,104.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas SPAL.NS's P/E ratio is 28.68. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to SPAL.NS's ROE of +0.11%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to SPAL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SPAL.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, SPAL.BO has a market cap of 27.7B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while SPAL.BO trades at ₹1,103.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas SPAL.BO's P/E ratio is 27.47. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to SPAL.BO's ROE of +0.11%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to SPAL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SPAL.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, SANGAMIND.BO has a market cap of 27.1B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while SANGAMIND.BO trades at ₹546.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas SANGAMIND.BO's P/E ratio is 709.29. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to SANGAMIND.BO's ROE of +0.08%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to SANGAMIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SANGAMIND.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, BOMDYEING.BO has a market cap of 26.3B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while BOMDYEING.BO trades at ₹127.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas BOMDYEING.BO's P/E ratio is 97.85. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to BOMDYEING.BO's ROE of +0.01%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to BOMDYEING.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check BOMDYEING.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, SPORTKING.NS has a market cap of 23.4B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while SPORTKING.NS trades at ₹184.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas SPORTKING.NS's P/E ratio is 19.44. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to SPORTKING.NS's ROE of +0.11%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to SPORTKING.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SPORTKING.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, SPORTKING.BO has a market cap of 23.2B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while SPORTKING.BO trades at ₹184.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas SPORTKING.BO's P/E ratio is 19.47. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to SPORTKING.BO's ROE of +0.11%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to SPORTKING.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SPORTKING.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, CANTABIL.NS has a market cap of 22.3B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while CANTABIL.NS trades at ₹266.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas CANTABIL.NS's P/E ratio is 22.91. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to CANTABIL.NS's ROE of +0.23%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to CANTABIL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check CANTABIL.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, CANTABIL.BO has a market cap of 22.3B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while CANTABIL.BO trades at ₹266.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas CANTABIL.BO's P/E ratio is 22.08. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to CANTABIL.BO's ROE of +0.23%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to CANTABIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check CANTABIL.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, DOLLAR.BO has a market cap of 15.6B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while DOLLAR.BO trades at ₹275.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas DOLLAR.BO's P/E ratio is 14.61. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to DOLLAR.BO's ROE of +0.12%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to DOLLAR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check DOLLAR.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, DOLLAR.NS has a market cap of 15.6B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while DOLLAR.NS trades at ₹274.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas DOLLAR.NS's P/E ratio is 15.60. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to DOLLAR.NS's ROE of +0.12%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to DOLLAR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check DOLLAR.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, FAZE3Q.NS has a market cap of 14.9B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while FAZE3Q.NS trades at ₹613.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas FAZE3Q.NS's P/E ratio is 54.24. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to FAZE3Q.NS's ROE of +0.08%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to FAZE3Q.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check FAZE3Q.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, RUPA.NS has a market cap of 13.8B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while RUPA.NS trades at ₹173.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas RUPA.NS's P/E ratio is 15.55. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to RUPA.NS's ROE of +0.07%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to RUPA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check RUPA.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, RUPA.BO has a market cap of 13.7B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while RUPA.BO trades at ₹172.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas RUPA.BO's P/E ratio is 18.99. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to RUPA.BO's ROE of +0.07%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to RUPA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check RUPA.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, CENTENKA.NS has a market cap of 11.5B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while CENTENKA.NS trades at ₹525.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas CENTENKA.NS's P/E ratio is 12.45. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to CENTENKA.NS's ROE of +0.07%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to CENTENKA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check CENTENKA.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, MONTECARLO.BO has a market cap of 11.4B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while MONTECARLO.BO trades at ₹550.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas MONTECARLO.BO's P/E ratio is 10.19. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to MONTECARLO.BO's ROE of +0.13%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to MONTECARLO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check MONTECARLO.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, CENTENKA.BO has a market cap of 11.4B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while CENTENKA.BO trades at ₹523.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas CENTENKA.BO's P/E ratio is 11.34. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to CENTENKA.BO's ROE of +0.07%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to CENTENKA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check CENTENKA.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, MONTECARLO.NS has a market cap of 11.4B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while MONTECARLO.NS trades at ₹549.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas MONTECARLO.NS's P/E ratio is 10.17. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to MONTECARLO.NS's ROE of +0.13%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to MONTECARLO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check MONTECARLO.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, HIMATSEIDE.BO has a market cap of 11.2B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while HIMATSEIDE.BO trades at ₹88.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas HIMATSEIDE.BO's P/E ratio is 17.15. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to HIMATSEIDE.BO's ROE of +0.03%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to HIMATSEIDE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check HIMATSEIDE.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, HIMATSEIDE.NS has a market cap of 11.2B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while HIMATSEIDE.NS trades at ₹88.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas HIMATSEIDE.NS's P/E ratio is 13.78. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to HIMATSEIDE.NS's ROE of +0.03%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to HIMATSEIDE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check HIMATSEIDE.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, GHCLTEXTIL.BO has a market cap of 10.6B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while GHCLTEXTIL.BO trades at ₹110.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas GHCLTEXTIL.BO's P/E ratio is 22.82. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to GHCLTEXTIL.BO's ROE of +0.05%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to GHCLTEXTIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check GHCLTEXTIL.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, GHCLTEXTIL.NS has a market cap of 10.6B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while GHCLTEXTIL.NS trades at ₹110.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas GHCLTEXTIL.NS's P/E ratio is 23.48. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to GHCLTEXTIL.NS's ROE of +0.05%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to GHCLTEXTIL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check GHCLTEXTIL.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, AMBIKCO.BO has a market cap of 9.9B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while AMBIKCO.BO trades at ₹1,723.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas AMBIKCO.BO's P/E ratio is 13.79. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to AMBIKCO.BO's ROE of +0.08%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to AMBIKCO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check AMBIKCO.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, AMBIKCO.NS has a market cap of 9.9B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while AMBIKCO.NS trades at ₹1,721.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas AMBIKCO.NS's P/E ratio is 13.78. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to AMBIKCO.NS's ROE of +0.08%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to AMBIKCO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check AMBIKCO.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, NAHARSPING.BO has a market cap of 9.8B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while NAHARSPING.BO trades at ₹267.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas NAHARSPING.BO's P/E ratio is 44.43. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to NAHARSPING.BO's ROE of +0.01%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to NAHARSPING.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check NAHARSPING.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, NAHARSPING.NS has a market cap of 9.6B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while NAHARSPING.NS trades at ₹266.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas NAHARSPING.NS's P/E ratio is 34.17. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to NAHARSPING.NS's ROE of +0.01%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to NAHARSPING.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check NAHARSPING.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, PRECOT.NS has a market cap of 9.3B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while PRECOT.NS trades at ₹775.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas PRECOT.NS's P/E ratio is 32.91. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to PRECOT.NS's ROE of +0.08%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to PRECOT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check PRECOT.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, RSWM.BO has a market cap of 9.3B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while RSWM.BO trades at ₹202.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas RSWM.BO's P/E ratio is 18.28. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to RSWM.BO's ROE of +0.04%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to RSWM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check RSWM.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, RSWM.NS has a market cap of 9.3B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while RSWM.NS trades at ₹196.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas RSWM.NS's P/E ratio is 17.82. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to RSWM.NS's ROE of +0.04%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to RSWM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check RSWM.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, SARLAPOLY.NS has a market cap of 8.9B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while SARLAPOLY.NS trades at ₹107.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas SARLAPOLY.NS's P/E ratio is -67.77. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to SARLAPOLY.NS's ROE of -0.03%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to SARLAPOLY.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SARLAPOLY.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, IRISDOREME.NS has a market cap of 7.4B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while IRISDOREME.NS trades at ₹43.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas IRISDOREME.NS's P/E ratio is 43.49. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to IRISDOREME.NS's ROE of +0.15%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to IRISDOREME.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check IRISDOREME.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, UNITEDPOLY.NS has a market cap of 7.3B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while UNITEDPOLY.NS trades at ₹31.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas UNITEDPOLY.NS's P/E ratio is 12.53. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to UNITEDPOLY.NS's ROE of +0.23%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to UNITEDPOLY.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check UNITEDPOLY.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, SUTLEJTEX.BO has a market cap of 6.4B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while SUTLEJTEX.BO trades at ₹38.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas SUTLEJTEX.BO's P/E ratio is -7.30. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to SUTLEJTEX.BO's ROE of -0.10%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to SUTLEJTEX.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SUTLEJTEX.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, SUTLEJTEX.NS has a market cap of 6.2B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while SUTLEJTEX.NS trades at ₹37.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas SUTLEJTEX.NS's P/E ratio is -7.14. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to SUTLEJTEX.NS's ROE of -0.10%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to SUTLEJTEX.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SUTLEJTEX.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, ORBTEXP.NS has a market cap of 6.1B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while ORBTEXP.NS trades at ₹231.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas ORBTEXP.NS's P/E ratio is 18.84. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to ORBTEXP.NS's ROE of +0.11%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to ORBTEXP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check ORBTEXP.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, ORBTEXP.BO has a market cap of 6B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while ORBTEXP.BO trades at ₹230.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas ORBTEXP.BO's P/E ratio is 18.73. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to ORBTEXP.BO's ROE of +0.11%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to ORBTEXP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check ORBTEXP.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, PASUPTAC.NS has a market cap of 5.5B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while PASUPTAC.NS trades at ₹61.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas PASUPTAC.NS's P/E ratio is 7.86. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to PASUPTAC.NS's ROE of +0.18%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to PASUPTAC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check PASUPTAC.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, NAHARINDUS.NS has a market cap of 5.1B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while NAHARINDUS.NS trades at ₹117.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas NAHARINDUS.NS's P/E ratio is 9.88. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to NAHARINDUS.NS's ROE of +0.05%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to NAHARINDUS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check NAHARINDUS.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, GINNIFILA.NS has a market cap of 4.7B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while GINNIFILA.NS trades at ₹54.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas GINNIFILA.NS's P/E ratio is 12.59. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to GINNIFILA.NS's ROE of +0.17%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to GINNIFILA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check GINNIFILA.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, SINTEX.NS has a market cap of 4.7B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while SINTEX.NS trades at ₹7.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas SINTEX.NS's P/E ratio is -0.33. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to SINTEX.NS's ROE of -0.36%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to SINTEX.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SINTEX.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, GINNIFILA.BO has a market cap of 4.7B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while GINNIFILA.BO trades at ₹54.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas GINNIFILA.BO's P/E ratio is 12.57. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to GINNIFILA.BO's ROE of +0.17%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to GINNIFILA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check GINNIFILA.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, DONEAR.NS has a market cap of 4.5B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while DONEAR.NS trades at ₹86.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas DONEAR.NS's P/E ratio is 14.99. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to DONEAR.NS's ROE of +0.11%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to DONEAR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check DONEAR.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, DONEAR.BO has a market cap of 4.5B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while DONEAR.BO trades at ₹86.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas DONEAR.BO's P/E ratio is 16.15. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to DONEAR.BO's ROE of +0.11%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to DONEAR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check DONEAR.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, BANSWRAS.NS has a market cap of 4.5B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while BANSWRAS.NS trades at ₹130.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas BANSWRAS.NS's P/E ratio is 11.63. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to BANSWRAS.NS's ROE of +0.06%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to BANSWRAS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check BANSWRAS.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, BANSWRAS.BO has a market cap of 4.5B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while BANSWRAS.BO trades at ₹130.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas BANSWRAS.BO's P/E ratio is 14.29. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to BANSWRAS.BO's ROE of +0.06%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to BANSWRAS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check BANSWRAS.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, VISHAL.NS has a market cap of 4.3B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while VISHAL.NS trades at ₹22.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas VISHAL.NS's P/E ratio is 16.70. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to VISHAL.NS's ROE of +0.07%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to VISHAL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check VISHAL.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, NDL.NS has a market cap of 3.5B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while NDL.NS trades at ₹2.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas NDL.NS's P/E ratio is 10.39. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to NDL.NS's ROE of +0.05%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to NDL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check NDL.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, NDL.BO has a market cap of 3.4B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while NDL.BO trades at ₹2.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas NDL.BO's P/E ratio is 10.07. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to NDL.BO's ROE of +0.05%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to NDL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check NDL.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, VARDMNPOLY.NS has a market cap of 3.3B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while VARDMNPOLY.NS trades at ₹6.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas VARDMNPOLY.NS's P/E ratio is 35.59. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to VARDMNPOLY.NS's ROE of -0.04%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to VARDMNPOLY.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check VARDMNPOLY.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, SOMATEX.BO has a market cap of 3.2B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while SOMATEX.BO trades at ₹98.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas SOMATEX.BO's P/E ratio is 388.87. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to SOMATEX.BO's ROE of +0.06%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to SOMATEX.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SOMATEX.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, SOMATEX.NS has a market cap of 3.2B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while SOMATEX.NS trades at ₹98.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas SOMATEX.NS's P/E ratio is 31.10. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to SOMATEX.NS's ROE of +0.06%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to SOMATEX.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SOMATEX.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, AXITA.NS has a market cap of 2.9B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while AXITA.NS trades at ₹7.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas AXITA.NS's P/E ratio is 135.51. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to AXITA.NS's ROE of +0.03%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to AXITA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check AXITA.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, AXITA.BO has a market cap of 2.9B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while AXITA.BO trades at ₹7.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas AXITA.BO's P/E ratio is 135.51. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to AXITA.BO's ROE of +0.03%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to AXITA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check AXITA.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, DCMNVL.BO has a market cap of 2.9B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while DCMNVL.BO trades at ₹158.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas DCMNVL.BO's P/E ratio is 158.95. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to DCMNVL.BO's ROE of +0.01%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to DCMNVL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check DCMNVL.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, DCMNVL.NS has a market cap of 2.9B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while DCMNVL.NS trades at ₹153.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas DCMNVL.NS's P/E ratio is 154.37. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to DCMNVL.NS's ROE of +0.01%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to DCMNVL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check DCMNVL.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, ASHIMASYN.BO has a market cap of 2.7B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while ASHIMASYN.BO trades at ₹14.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas ASHIMASYN.BO's P/E ratio is -27.40. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to ASHIMASYN.BO's ROE of -0.07%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to ASHIMASYN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check ASHIMASYN.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, SPYL.BO has a market cap of 2.6B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while SPYL.BO trades at ₹7.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas SPYL.BO's P/E ratio is 1.62. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to SPYL.BO's ROE of -2.21%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to SPYL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SPYL.BO's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, SPYL.NS has a market cap of 2.5B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while SPYL.NS trades at ₹7.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas SPYL.NS's P/E ratio is 1.60. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to SPYL.NS's ROE of -2.21%. Regarding short-term risk, ASHIMASYN.NS is more volatile compared to SPYL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check SPYL.NS's competition here

ASHIMASYN.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ASHIMASYN.NS stands at 2.8B. In comparison, VIPCLOTHNG.NS has a market cap of 2.3B. Regarding current trading prices, ASHIMASYN.NS is priced at ₹14.43, while VIPCLOTHNG.NS trades at ₹25.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ASHIMASYN.NS currently has a P/E ratio of -14.58, whereas VIPCLOTHNG.NS's P/E ratio is 23.01. In terms of profitability, ASHIMASYN.NS's ROE is -0.07%, compared to VIPCLOTHNG.NS's ROE of +0.05%. Regarding short-term risk, ASHIMASYN.NS is less volatile compared to VIPCLOTHNG.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASHIMASYN.NS.Check VIPCLOTHNG.NS's competition here